ILSI-Biomed Israel

Israeli biotech – Good for what ails you

Israel is the world leader in patents for medical devices, relative to population size, and second in the patenting of biopharm products, including pharmaceuticals and treatments. Israel is eighth in the number of patents granted in the life-sciences industry, which may be the most amazing statistic of all, given the amount of time and money companies must invest in getting a product or technology tested and patented. This week, the Israeli biotech industry was having its annual confer...

Some photos from ILSI-Biomed

Photo credit: Ilan Levi www.ilanlevi.com More photos are available at our Facebook page. Tweet

Shimon Peres to raise funds for Israeli brain research

President Shimon Peres announced at the 10th ILSI-Biomed Conference 2011 today that he will set up a non-profit organization to support brain research in Israel, which will be headed by Dr. Rafi Gidron. Gidron, a co-founder of Chromatis Networks, which was sold to Lucent for over $4 billion in 2000, is currently involved in volunteer work and invests in cleantech companies through his firm Precede Technologies Ltd. The aim of the proposed NPO will be to shift the emphasis of research in ...

Want to win an iPad2 at ILSI-Biomed?

ILSI-Biomed starts tomorrow! Want to win an iPad2 at ILSI-Biomed? Shizim's iPad2 lottery campaign for Biomed companies: Tell us about your company, and get a chance to win an iPad2 ! Tweet To download the participation form: http://www.lsahome.com/competition/application_2011_iPad.doc

ILSI-Biomed 2011: Israel’s Chief Scientist Reports a 430 million NIS Investment in Life Science Industries and Announces the Field as a Favored Sector

In 2010, the Israeli Chief Scientist approved a total of NIS 430 million in various program budgets. The R&D Committee alone considered 338 support applications from 193 companies for life science projects. 265 projects were approved for State assistance. Statistical reports prepared by the Israeli Chief Scientist office towards the ILSI – Biomed Israel 2011 Week, which will open in Tel Aviv next week (May 23-25, 2011), show that the Chief Scientist helped support life science projects in...

Abbott Diagnostics @ Biomed 2011

Abbott Diagnostics will be attending Biomed 2011 and is interested in discussions with potential collaborators leading toward the development and commercialization of novel IA/CC biomarkers in all therapeutic areas: o Evidence of clinical utility o Well characterized antibody development o Preferably, a developed ELISA format o Workable, defendable, global IP position Tweet

Italy-Israel Bilateral conference during Biomed 2011

The Embassy of Italy in Tel Aviv In collaboration with Israel Italy Chamber of Commerce and Industry Cordially invite you to attend the FIFTH Italian Israeli Conference on Life Sciences: “Collaboration and Innovation in Cancer Research and Treatment” Tuesday, May 24, 2011 Dan Panorama Hotel, Tel Aviv From 09.00 to 13.00 for informations info@italia-israel.com Tweet

Local management vs. International management

In preparation for the closing session of the upcoming ILSI biomed conference, dealing with the issue of local management vs. international management, ILSI-Biomed is conducting a survey to assess current attitudes towards management of an Israeli start up companies. The session will be led by Dr Dalia Megiddo. If you could answer a few short questions, your name and company will be kept confidential. 1. Is in necessary at some point in an Israeli healthcare company's life c...

Meet The Speakers: Shlomo Yanai

The ILSI-BioMed week is closer every day. It will be opened by a keynote address by Mr. Shlomo Yanai, President and CEO of Teva, Israel. Shlomo Yanai has been the President and Chief Executive Officer of Teva since March 2007. Prior to joining Teva, Mr. Yanai was President and Chief Executive Officer of Makhteshim-Agan Industries Ltd. from 2003 until 2006. Previously, Mr. Yanai served in the Israel Defense Forces (the "IDF") for 32 years, where he achieved the rank of Major General, t...

Meet the speakers: Dalia Megiddo

Dr. Dalia Megiddo managed 2 venture capital funds: 7 Health Ventures (2006-2010) and InnoMed Ventures, since 2000. Dr Megiddo has been involved in the Life Science Venture Capital Industry since 1999 and is well recognized as one of the leaders in the healthcare investment community both in Israel and internationally. She is a frequent speaker at local and international meetings and served as a board member at Given Imaging (NASDAQ-GIVN) and Elron (NASDAQ- ELRN). She is also involved in f...